Nafoxidine
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine
|
|
Identifiers | |
CAS Number | 1845-11-0 |
ATC code | none |
PubChem | CID: 4416 |
IUPHAR/BPS | 4263 |
ChemSpider | 4263 |
UNII | 4RIY10WM82 ![]() |
ChEMBL | CHEMBL28211 |
Chemical data | |
Formula | C29H31NO2 |
Molecular mass | 425.562 g/mol |
|
Nafoxidine (U-11,000A) is a non-steroidal antiestrogenic drug that has been investigated to treat advanced breast cancer.[1] It is structurally related to tamoxifen.
The drug is one of a series of similar structures invented at Upjohn. An earlier compound known as U-11,555 is related to Nafoxidine was found to cause photosensitivity in human volunteers.[2][3]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://www.sciencebase.com/serendipity_and_science.html
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Experimental cancer drugs
- Pyrrolidines
- Phenol ethers
- Abandoned drugs
- Selective estrogen receptor modulators
- Antineoplastic and immunomodulating drug stubs